Stereotaxis, Inc. (STXS)
Company Description
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room.
In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters.
Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components.
The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology.
Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.
| Country | United States |
| Founded | 1990 |
| IPO Date | Aug 12, 2004 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 130 |
| CEO | Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA |
Contact Details
Address: 710 N Tucker Blvd, Ste 110 St.louis, Missouri 63101 United States | |
| Phone | 314-678-6100 |
| Website | stereotaxis.com |
Stock Details
| Ticker Symbol | STXS |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001289340 |
| CUSIP Number | 85916J409 |
| ISIN Number | US85916J4094 |
| Employer ID | 94-3120386 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A., CFA, CPA | Chief Executive Officer and Chairman |
| Kimberly R. Peery | Chief Financial Officer and Secretary |
| Keith Galloway | Vice President of Operations |
| Laura Spencer Garth | General Counsel |
| John Platt | Senior Director of Project Management and Systems Software |
| Nathan Kastelein | R&D Leader and Senior Director of Research & Development and Advanced Concepts |
| Brian Kidd | R&D Leader and Senior Director of Product Development |
| Guy Judkowski | Equity Portfolio Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 11, 2023 | 10-Q | Quarterly Report |
| Aug 10, 2023 | 8-K | Current Report |
| Jun 15, 2023 | 8-K | Current Report |
| Jun 6, 2023 | EFFECT | Notice of Effectiveness |
| Jun 6, 2023 | EFFECT | Notice of Effectiveness |
| Jun 1, 2023 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| May 26, 2023 | SD | Form - SD |
| May 19, 2023 | S-3 | Registration statement under Securities Act of 1933 |
| May 19, 2023 | S-3 | Registration statement under Securities Act of 1933 |
| May 19, 2023 | 8-K | Current Report |